Schedule 13G ownership disclosure

Century Therapeutics, Inc.

Common Stock, par value $0.0001 per share · CUSIP: 15673T100

Event date: 2025-12-23

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Point72 Asset Management, L.P.

    Shares: 4,725,639.00 · Class: 5.4%

  • Point72 Capital Advisors, Inc.

    Shares: 4,725,639.00 · Class: 5.4%

  • Steven A. Cohen

    Shares: 4,725,639.00 · Class: 5.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-26-000035
Form type
SCHEDULE 13G
Filer
Century Therapeutics, Inc.
CIK
CIK 1850119
Filed
Jan 05, 2026
Reporting period
Dec 23, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub